HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
TUESDAY, Aug. 9, 2022 (HealthDay News) -- There are sex-related differences in the detection, recognition, monitoring, referrals, and management of chronic kidney disease (CKD), according to a study published online July 29 in the Journal of the American Society of Nephrology.
Oskar Swartling, M.D., from the Karolinska Institutet in Stockholm, and colleagues assessed sex differences in CKD using data from 227,847 adults with probable CKD (at least one outpatient estimated glomerular filtration rate <60 mL/min per 1.73 m2 measurement from 2009 to 2017).
The researchers found that women had lower odds of having received a diagnostic code for CKD and were less likely to have received a renin-angiotensin system inhibitor and statins, despite the presence of guideline-recommended indications. Regardless of disease severity, presence of albuminuria, or criteria for referral, women were found to be less likely to have received a CKD diagnosis (hazard ratio, 0.43) and visited a nephrologist (hazard ratio, 0.46). Even among women with diabetes or hypertension, women were also less likely to undergo monitoring of creatinine or albuminuria. When adjusting for comorbidities, albuminuria, and highest educational achievement and among individuals with confirmed CKD at retesting, sex-related associations persisted. Despite improvements in nephrology-care indicators over time, the observed sex gap persisted.
"Efforts to improve and ensure equitable health care between the sexes could have important implications for justice and could reduce the burden of CKD," the authors write.
Several authors disclosed financial ties to the pharmaceutical industry.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Updated on September 21, 2022